US cannabis rescheduling and ETF liquidity reset

Conviction: 78% · Horizon: 6M · 2026-07-02
Federal rescheduling hearings and improving index composition set up a late-year repricing in US cannabis equities

A recreational rescheduling hearing runs through mid-July, after which an administrative law judge recommendation and a DEA final rule can clarify the regulatory path. Near term, price action may consolidate while holding above key moving averages. Structurally, concentration in liquid, exchange-listed operators reduces the liquidity drag that weighed on the sector, improving the odds of momentum into the second half of the year.

Instrument Side Target Reason
MSOS Long 10 A visible federal rescheduling process, supportive technicals above the 50- and 200-day averages, and a cleaner liquidity profile in the underlying basket argue for asymmetric upside as policy clarity and institutional access improve through year-end.

Themes

The content on this page is for informational purposes only and does not constitute financial advice. Stoquate is not a licensed financial advisor. Always conduct your own research and consult a qualified professional before making any investment decisions.